CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01911 CR HOLDINGS

Trading 08-31 09:32:49

3.410

-0.005

-0.15%

High3.410	Low3.410	Vol10.00K
Open3.410	D1 Closing3.415	Amplitude0.00%
Mkt Cap1.95B	Tradable Cap1.95B	Total Shares573.00M
T/O34.10K	T/O Rate0.00%	Tradable Shares573.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01911","market":"HK","secType":"STK","nameCN":"CR HOLDINGS","latestPrice":3.41,"timestamp":1788139812053,"preClose":3.415,"halted":0,"volume":10000,"delay":0,"changeRate":-0.0014641288433381826,"floatShares":573000000,"shares":573000000,"eps":0.19,"marketStatus":"Trading","change":-0.005,"latestTime":"08-31 09:32:49","open":3.41,"high":3.41,"low":3.41,"amount":34100,"amplitude":0,"askPrice":3.41,"askSize":23000,"bidPrice":3.305,"bidSize":4200,"shortable":0,"etf":0,"ttmEps":0.154,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788148800000},"marketStatusCode":2,"adr":0,"listingDate":1537977600000,"exchange":"SEHK","adjPreClose":3.415,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":1.573992,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01911","defaultTab":"news","newsList":[{"id":"2662086799","title":"Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662086799?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:51","pubTimestamp":1787842274,"startTime":"0","endTime":"0","summary":"Innovent Biologics files HKEX next-day disclosure return, issues 182,021 new sharesInnovent filed a next-day disclosure return on Aug. 27, 2026 for share issuances from option exercises.Issued 182,021","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL82CCyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1188198961.HKD","LU1969619763.USD","BK1147","LU2097828805.USD","LU0244354667.USD","01801","LU2488822045.USD","LU2097828631.EUR","BK1589","LU2242644610.SGD","LU2097828557.USD","HK0000165453.HKD","LU2328871848.SGD","01911","LU0463099449.HKD","LU2097828474.EUR","LU0502904849.HKD","LU0326950275.SGD","LU0455707207.USD","BK1161","LU2097828714.EUR","BK1583","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662968777","title":"China Renaissance H1 Revenue Falls 3% as Management Fees Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2662968777","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662968777?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:23","pubTimestamp":1787822611,"startTime":"0","endTime":"0","summary":"China Renaissance H1 revenue falls 3% as management fees dropOverviewChina investment bank's H1 revenue fell 3% yr/yr as management fees declinedNet income attributable to owners dropped to RMB40.5 ml","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","NOAH","601375","01911","BK1147","BK4588","BK0201","BK4585","BK4135","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139707721","title":"CR Holdings Posts 37.7% Drop in Mid-Year Profit to 40.47 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1139707721","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139707721?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:21","pubTimestamp":1787822463,"startTime":"0","endTime":"0","summary":"CR Holdings (01911) has unveiled its interim results for 2026, with total revenue coming in at approximately 412 million yuan, a year-on-year decline of 3.05%. Meanwhile, the combined figure for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662077221","title":"China Renaissance - Board Does not Recommend Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2662077221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662077221?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:11","pubTimestamp":1787821912,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662243772","title":"China Renaissance Holdings H1 Net Income Attributable RMB 40.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662243772","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662243772?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:11","pubTimestamp":1787821864,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXM6BW7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662772219","title":"China Renaissance FY26 H1 Profit Attributable to Owners Falls 37.72% to RMB 40.47 Million; Revenue Drops 3% to RMB 412.18 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662772219","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662772219?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:10","pubTimestamp":1787821851,"startTime":"0","endTime":"0","summary":"China Renaissance FY26 H1 profit attributable to owners falls 37.72% to RMB 40.47 million; revenue drops 3% to RMB 412.18 millionChina Renaissance posted IFRS profit attributable to owners of RMB 40.4","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8tDGPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732450","title":"China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732450","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732450?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:48","pubTimestamp":1787662122,"startTime":"0","endTime":"0","summary":"China's Innovent Biologics H1 revenue, profit rise on strong product salesOverviewChina biopharma firm's H1 revenue rose 44.8% yr/yr on strong product sales growthNet profit for H1 grew 50.2% yr/yr, s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000MB6IJN5.SGD","IE00BGHQF631.EUR","ABBV","AGNG","LU0456855351.SGD","LU2237443895.HKD","RXL","LU0965509283.SGD","IE0002141913.USD","FTXH","LU2148510915.USD","688331","LU1732800096.USD","IYH","LU0098860793.USD","LU0203345920.USD","SG9999015986.USD","KURE","LU0942090050.USD","PJP","IE00BLSP4452.SGD","LU0234572021.USD","01167","LU0170899867.USD","IE00B42XCP33.USD","VHT","IE00BVYPNW00.USD","LU2097828805.USD","688428","PPH","MEDX","LU1551013342.USD","LU1037948541.HKD","01801","LU1989772840.SGD","LU0203347892.USD","TRUH","XLV","GLAM","IE00B3PB1722.GBP","LU0455707207.USD","LU2097828631.EUR","FHLC","LU1496350171.SGD","LU2089283258.USD","IXJ","BK0239","LU0029864427.USD","01911","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733511","title":"Innovent Biologics H1 FY26 IFRS Profit Climbs 50.2% to RMB 1.25 Billion; Revenue Rises 44.8% to RMB 8.62 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733511","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733511?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:02","pubTimestamp":1787652152,"startTime":"0","endTime":"0","summary":"Innovent Biologics H1 FY26 IFRS profit climbs 50.2% to RMB 1.25 billion; revenue rises 44.8% to RMB 8.62 billionInnovent Biologics posted IFRS profit of RMB 1.25 billion, up 50.2% year over year, on r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDLZJBKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU0502904849.HKD","LU2097828805.USD","KURE","LU2488822045.USD","LU0463099449.HKD","LU2097828714.EUR","LU0244354667.USD","LU0455707207.USD","LU1188198961.HKD","01911","LU0326950275.SGD","LU2097828474.EUR","LU2328871848.SGD","HK0000165453.HKD","BK1589","LU2242644610.SGD","LU2097828631.EUR","LU2097828557.USD","BK1583","BK1161","LU1969619763.USD","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662202750","title":"Asian Penny Stocks: Spotlight On China Renaissance Holdings And Two More","url":"https://stock-news.laohu8.com/highlight/detail?id=2662202750","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662202750?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:02","pubTimestamp":1787608922,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of fluctuating economic indicators and investor sentiment, the Asian markets have been navigating a complex landscape, with varying performances across different indices. For those interested in exploring smaller or newer companies, penny stocks—despite their somewhat outdated moniker—continue to offer intriguing opportunities. By focusing on those with strong financials and potential for growth, investors can uncover valuable prospects within this segment of the market.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3112100-choice2-main-header/1585186903084","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112100-choice2-main-header/1585186903084"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/real-estate-management-and-development/hkg-2869/greentown-service-group-shares/news/asian-penny-stocks-spotlight-on-china-renaissance-holdings-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/real-estate-management-and-development/hkg-2869/greentown-service-group-shares/news/asian-penny-stocks-spotlight-on-china-renaissance-holdings-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999014484.SGD","SG9999002406.SGD","LU2663582299.SGD","LU1508157978.USD","F34.SI","SG9999013460.SGD","SG9999003826.SGD","SG9999013478.USD","BK6095","SG9999016042.SGD","SG9999014492.USD","01911","SG9999002679.SGD","BK6509","SG9999004360.SGD","SGXZ58947870.SGD","SG9999002414.USD","SG9999013486.USD","BK1147","SG9999014302.SGD","SG9999000343.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115057484","title":"CR Holdings Schedules 27 Aug 2026 Board Meeting to Review 1H 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1115057484","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115057484?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:27","pubTimestamp":1786699667,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (CR Holdings) has announced that its board of directors will convene on 27 August 2026 to consider and approve the group’s interim results for the six months ended...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659566112","title":"China Renaissance Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659566112","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659566112?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:01","pubTimestamp":1786698091,"startTime":"0","endTime":"0","summary":"China Renaissance schedules board meeting to review interim resultsChina Renaissance set a board meeting for Aug. 27, 2026 to consider interim results for the six months ended June 30, 2026.Disclaimer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL6gNsHR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658475981","title":"Innovent Biologics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658475981","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658475981?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:05","pubTimestamp":1786352720,"startTime":"0","endTime":"0","summary":"Innovent Biologics schedules board meeting to review interim resultsInnovent Biologics set a board meeting for Aug. 25, 2026 to review interim results for the six months ended June 30, 2026.Disclaimer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLbzWXSb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU2097828474.EUR","HK0000165453.HKD","LU1188198961.HKD","LU2097828714.EUR","BK1147","BK1589","01801","BK1161","BK1583","01911","LU1969619763.USD","LU2097828557.USD","LU2097828631.EUR","LU0244354667.USD","LU2242644610.SGD","LU0455707207.USD","LU0463099449.HKD","LU0502904849.HKD","LU2097828805.USD","LU2328871848.SGD","LU2488822045.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658605620","title":"Innovent Biologics Signs Exclusive Deal with Daiichi Sankyo to Commercialize Vanflyta in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658605620","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658605620?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:00","pubTimestamp":1786320019,"startTime":"0","endTime":"0","summary":"Innovent Biologics signs exclusive deal with Daiichi Sankyo to commercialize Vanflyta in ChinaInnovent Biologics signed an exclusive deal with Daiichi Sankyo to commercialize Vanflyta (quizartinib) in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL9YX0hZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","01911","LU0244354667.USD","LU2097828805.USD","BK1589","LU2097828631.EUR","LU2242644610.SGD","LU2097828714.EUR","LU2097828557.USD","BK1147","KURE","LU2488822045.USD","LU0455707207.USD","LU0463099449.HKD","BK1583","LU0502904849.HKD","HK0000165453.HKD","LU1969619763.USD","LU2328871848.SGD","01801","LU1188198961.HKD","BK1161","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657606599","title":"Innovent Biologics Jumps Most in 3 Weeks on Robust Product Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657606599","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657606599?lang=en_us&edition=fundamental","pubTime":"2026-08-05 09:52","pubTimestamp":1785894772,"startTime":"0","endTime":"0","summary":"BUZZ-Innovent Biologics jumps most in 3 weeks on robust product revenue growth** Shares of Innovent Biologics Inc1801.HKjump 6.3% to HK$92.2, on track for the biggest one-day pct gain since July 15** Stock touches the highest level since July 24 in the second session of gain** The innovative medicine developer and producer says itsfirst half 2026 product revenueexceeds 8.2 bln yuan , up over 55% y/y, of which total revenue for the second quarter is up 60% y/y to over 4.3 bln yuan** YTD, stock up 18%, Hang Seng Biotech Index.HSBIOup 0.6%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N44201W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","BK1147","HK0000165453.HKD","LU2488822045.USD","01911","LU2097828474.EUR","LU2097828631.EUR","BK1583","LU2097828805.USD","LU0502904849.HKD","BK1589","LU2242644610.SGD","BK1161","LU2097828557.USD","KURE","LU1969619763.USD","LU2328871848.SGD","LU0455707207.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653122295","title":"China Renaissance Deploys $12 Million in Three-Month Fiduciary Time Deposit","url":"https://stock-news.laohu8.com/highlight/detail?id=2653122295","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653122295?lang=en_us&edition=fundamental","pubTime":"2026-07-21 15:42","pubTimestamp":1784619724,"startTime":"0","endTime":"0","summary":"China Renaissance  placed a $12 million three-month fiduciary time deposit through LGT Bank, with the funds deposited at CTBC Bank, according to a Monday Hong Kong bourse filing.The deposit carries an annual interest rate of 4.08% and is scheduled to mature on or about Oct. 22. The investment is part of the group's treasury management strategy to enhance returns on its working capital.Shares of the company fell 1% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178279999","title":"CR HOLDINGS Allocates $12 Million to Trust Deposits","url":"https://stock-news.laohu8.com/highlight/detail?id=1178279999","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178279999?lang=en_us&edition=fundamental","pubTime":"2026-07-20 22:06","pubTimestamp":1784556381,"startTime":"0","endTime":"0","summary":"CR HOLDINGS (HKEX: 01911) has announced that on July 20, 2026, the group, through its wholly-owned subsidiary acting as the subscriber, has subscribed for trust deposits with a total principal amount...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168470345","title":"CR HOLDINGS places USD 12.00 million fiduciary time deposit with LGT Bank at 4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168470345","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168470345?lang=en_us&edition=fundamental","pubTime":"2026-07-20 22:02","pubTimestamp":1784556143,"startTime":"0","endTime":"0","summary":"CR HOLDINGS (China Renaissance Holdings Limited) disclosed that on 20 July 2026 its wholly-owned subsidiary, China Renaissance Capital Limited, subscribed to a USD-denominated fiduciary time deposit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652219977","title":"China Renaissance - Places US$12 Mln Fiduciary Deposit Through Lgt on July 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652219977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652219977?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:56","pubTimestamp":1784555786,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190083303","title":"CR HOLDINGS Appoints Liu Taojiang to Lead Hong Kong Stock Investment Banking","url":"https://stock-news.laohu8.com/highlight/detail?id=1190083303","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190083303?lang=en_us&edition=fundamental","pubTime":"2026-07-20 15:10","pubTimestamp":1784531439,"startTime":"0","endTime":"0","summary":"On July 20, CR HOLDINGS (ASX: 01911) announced that Mr. Liu Taojiang has officially joined the company as Managing Director and Head of Hong Kong Stock Investment Banking.Mr. Liu will be fully...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","BK4588","DFNL","01911","RSPF","BK1147","IYG","BK4585","VXUS","FYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651714291","title":"Innovent Biologics Licenses Anti-cd40l Antibody Ibi355 to Spero in Deal Worth About USD 1.1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2651714291","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651714291?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:01","pubTimestamp":1784023267,"startTime":"0","endTime":"0","summary":"Innovent Biologics licenses anti-CD40L antibody IBI355 to Spero in deal worth about USD 1.1 billionInnovent Biologics signed an exclusive license with Spero Therapeutics for IBI355 (SP001), a Phase 2-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL8vw8t6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU0502904849.HKD","LU2097828805.USD","KURE","LU2488822045.USD","LU2097828714.EUR","LU0455707207.USD","BK4139","01911","LU2097828474.EUR","LU2328871848.SGD","HK0000165453.HKD","BK1589","LU2242644610.SGD","LU2097828631.EUR","SPRO","LU2097828557.USD","BK1583","BK1161","LU1969619763.USD","BK1147"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinarenaissance.com","stockEarnings":[{"period":"1week","weight":0.0722},{"period":"1month","weight":0.0739},{"period":"3month","weight":0.0255},{"period":"6month","weight":-0.163},{"period":"1year","weight":-0.6001},{"period":"ytd","weight":-0.1731}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.016},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0234},{"period":"ytd","weight":-0.0018}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Renaissance Holdings Ltd is a holding company that is primarily engaged in providing investment banking and investment management services. The Company operates in four segments. Investment Banking segment provides early to late stage financial advisory and mergers and acquisitions advisory services, equity underwriting, sales, trading, brokerage, research services and structured financial services. Investment Management segment provides fund and asset management and manages its own investments in funds. China Renaissance (CR) Securities segment provides investment banking and asset management business. Others segment mainly includes wealth management business and investment and management of own funds.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.099096},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.014364},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.054298},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.054187},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.049653},{"month":6,"riseRate":0.833333,"avgChangeRate":0.099698},{"month":7,"riseRate":0.5,"avgChangeRate":0.05207},{"month":8,"riseRate":0.666667,"avgChangeRate":0.100851},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.131486},{"month":10,"riseRate":0,"avgChangeRate":-0.130048},{"month":11,"riseRate":0.285714,"avgChangeRate":0.027229},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.035994}],"exchange":"SEHK","name":"CR HOLDINGS","nameEN":"CR HOLDINGS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CR HOLDINGS,01911,CR HOLDINGS股票,CR HOLDINGS股票老虎,CR HOLDINGS股票老虎国际,CR HOLDINGS行情,CR HOLDINGS股票行情,CR HOLDINGS股价,CR HOLDINGS股市,CR HOLDINGS股票价格,CR HOLDINGS股票交易,CR HOLDINGS股票购买,CR HOLDINGS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}